Navigation Links
IBM and EU Partners Create a Better Way to Fight AIDS Virus
Date:6/2/2009

EuResist HIV Treatment Prediction Tool Wins Top Honors in Computerworld Honors Program

WASHINGTON, June 2 /PRNewswire-FirstCall/ -- IBM (NYSE: IBM) today announced it was selected for its contributions to the EuResist research project for AIDS treatment as a Computerworld Honors Program Laureate for 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090416/IBMLOGO )

Developed by IBM researchers in Haifa, Israel, the project's new technologies and mathematical models are providing a smarter and more efficient way to choose the best drugs combinations for any given HIV genetic variant. EuResist is a powerful online system that helps doctors choose the treatment with the highest probability of halting virus replication and impairing evolution of drug resistance.

Although there have been tremendous leaps and bounds in the management of the virus that causes AIDS, HIV has the ability to develop resistance to any antiretroviral compound. This means that doctors need to continuously monitor and prescribe new therapies for the treatment to remain effective. Keeping HIV under control is dependant on choosing the right combination of drugs that work for the longest period of time.

EuResist is the first and only freely available data-driven computational method that predicts the success of a treatment regimen against any given HIV genotype, based not only on viral genotype information, but using analytic technologies to take into account treatment response information from clinical practice. It is also the only system providing the global medical community with an estimate of activity for combination therapy, rather than for individual drugs.

Researchers behind the EU-funded EuResist project have developed new mathematical prediction models that not only take into account the patient's own history, but tap into the wealth of information that EuResist researchers have amassed. The recent expansion of the EuResist database to include information from more than 33,000 patients and 98,000 therapies, and 370,000 viral load measurements, makes it the world's biggest database centered on HIV resistance and clinical response information.

"EuResist has managed to create the largest clinically oriented antiretroviral drug resistance database in the world," explained Professor Maurizio Zazzi, EuResist Scientific Coordinator and Professor of Microbiology at the University of Siena School of Medicine." The ability to analyze clinical, laboratory and demographic data accumulated over the years significantly improves prediction of the right combination of drugs that works for the maximum amount of time." These innovations are being provided as a free tool that can help extend the lives of millions of people who are the victims of this disease.

The system's predictions are near 76% accurate, outperforming other commonly used HIV resistance prediction tools and also outperformed human experts in the field. To simulate real practice in HIV specialized care, the EVE (Engine versus Experts) study compared EuResist with 10 international experts confronted with 25 case histories, where all the clinical and virological information was available, EuResist's predictions outperformed nine out of ten human experts.

"The EuResist team feels both humbled and privileged by the opportunity to put good science and state-of-the-art technologies at the service of such an important and meaningful cause," noted Yardena Peres, researcher at the IBM Research Lab in Haifa and one of the leaders for the IBM contribution for the EuResist project.

Along with talent from the IBM Research Lab in Haifa, the brains behind the EuResist project come from the EuResist Network, a non-profit partnership of pharmaceutical companies, governmental institutions, and private companies, and its GEIE partners including a European Economic Interest Grouping composed of Karolinska Institute, Max Planck Institute, University of Siena, Informa s.r.l., University of Cologne.

About the Computerworld Honors Program

Founded by International Data Group (IDG) in 1988, the Computerworld Honors Program is governed by the not-for-profit Computerworld Information Technology Awards Foundation. In its 21st year, Computerworld Honors is the longest running global program to honor individuals and organizations that use information technology to benefit society.

Each year, the program's Chairmen's Committee, a group of 100 Chairmen/CEOs of global technology companies, nominates individuals and organizations around the world whose visionary application of information technology promotes positive social and economic progress. Nominations are evaluated by an independent board of CIO-level judges who select Laureates, Finalists and award recipients, in 10 industry-related categories, to be honored at the Laureate Medal Ceremony. This year's ceremony and accompanying Gala Awards Evening will take place on June 1, 2009 at the Andrew W. Mellon Auditorium in Washington, D.C.

The technology achievements honored by this program are preserved and protected in national archives, and in over 350 universities, museums and research institutions throughout the world. Additional information about the program and a Global Archive of past Laureate case studies and oral histories can be found at the Computerworld Honors website: www.cwhonors.org.

    Steven Tomasco
    IBM Media Relations
    Office - 914-945-1655
    Cell - 917-687-4588
    stomasc@us.ibm.com


'/>"/>
SOURCE IBM Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
5. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
6. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
7. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
8. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
9. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
10. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
11. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):